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ComplicationsAbstract Background: Morbidity related to vascular access is the leading cause of hospitalization
for chronic hemodialysis patients and is associated with high cost. Since data on vascular access
complications are scarce, this study was designed to focus on vascular access complications in
hemodialysis patients.
Methods: 119 patients with End Stage Renal Disease (ESRD) on regular hemodialysis were
recruited for the study, They were subjected to the following Laboratory blood tests: Kidney func-
tion tests, CBC, KT/V, serum albumin, fasting blood sugar, swab culture and sensitivity from the
skin over the vascular access and blood culture and sensitivity from both central and peripheral
samples, In addition, radiological Doppler ultrasound was done for all patients to evaluate the vas-
cular access.
Results: 27 out of 119 patients (22%) have positive blood culture, 64 (53.7%) patients have positive
swab culture, 68 (57%) patients have stenosis, 25 patients (21%) have athermanous plaques and 44
(36.9%) patients have aneurysmal dilatation. There was a signiﬁcant low Kt/V in patients with
stenosis and aneurysmal dilatation (p< 0.001). Low Kt/V, low serum albumin level and low
BMI were signiﬁcant in patients with central blood infection (p< 0.008, <0.008 and <0.001
respectively). There was signiﬁcant increase in the risk of infection in male patients, patients with
low BMI, increased BUN and increased duration of HD session (p< 0.046, <0.008, <0.002
and <0.009 respectively). Stenosis was the most common risk factor for vascular failure as it
68 T.A. Ghonemy et al.occurred in (29%) of patients. Diabetes was the second common risk factor for vascular failure as it
occurred in (17%) of patients.
Conclusion: Stenosis and infection are the most common complications of the vascular access. DM
is an important risk factor for the incidence of infection. Other risk factors for dialysis CRBSI
include older age, low serum albumin, high BUN and decreasing the duration of dialysis.
ª 2015 The Authors. Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Hemodialysis has become an increasingly safe and well-
tolerated therapy for patients with end-stage renal disease
(ESRD). Nevertheless, life expectancy of dialysis patients
remains signiﬁcantly shorter than that of the general popula-
tion with similar demographics.1 Arterio-venous ﬁstula
(AVF) is the preferred access for patients who require regular
Hemodialysis (HD) and the preferred site is the wrist, prefer-
ably in the non-dependant arm.2 A standard Arteriovenous ﬁs-
tula (AVF) is created from anastomosis of cephalic vein with
radial artery at the wrist. Tunneled dialysis catheters are used
for temporary vascular access in patients awaiting placement
or maturation of a permanent vascular access (AVF or AV
graft). They are also required for long-term access in patients
who have exhausted all options for placement of a permanent
access in all four extremities. They are usually placed in a cen-
tral vein in the chest, most commonly in the internal jugular
vein, and less commonly in the subclavian vein. However, they
can be used also in femoral veins whenever indicated and due
to their proximity to the groin; one would anticipate they
would be more prone to problems with low dialysis blood
ﬂows, loss of patency, and catheter-related bacteremia.4
Vascular access complications are of great burden in the
chronic hemodialysis population. Morbidity related to vascu-
lar access is the leading cause of frequent hospitalization
among chronic hemodialysis patients and is associated with
huge ﬁnancial problem. The Clinical Practice Guidelines for
Vascular Access of the National Kidney Foundation’s
Dialysis Outcomes Quality Initiative (KDOQI) recommend
use of arteriovenous (AV) accesses (native ﬁstulae or synthetic
grafts) for hemodialysis over using the venous catheter as they
provide higher blood ﬂow rates than do venous catheters and
are associated with lower rates of infection, thrombosis, sep-
ticemia, and central venous stenosis which are common com-
plications of the venous catheters. KDOQI Guidelines
further recommend ﬁstulae over grafts, as most studies have
found ﬁstulae to have fewer complications.5 Other complica-
tions of AVF include thrombosis, infection, bleeding,
increased venous pressure, arterial insufﬁciency, aneurysm,
carpal tunnel syndrome, distal ischemia and even heart fail-
ure.6 Since data on vascular access complications are scarce
in Egypt, this study was designed to focus on vascular access
complications and their common risk factors in Egyptian
hemodialysis patients.
2. Subjects and methods
This cross sectional study has been carried out in the nephrol-
ogy unit, and clinical biochemistry departments, ZagazigUniversity Hospitals, Egypt in the period between May 2012
and April 2014. One hundred and nineteen patients with
ESRD on regular HD were recruited for the study.
They were receiving bicarbonate base dialysis using a high
ﬂux polysulphonesynthetic dialyzer with an average blood ﬂow
of 300–350 mL/min, 3 times/week with target 4 h duration for
each dialysis session, 79 out of them were males and 40 were
females. Their ages ranged from 25 to 76 years with mean of
46.47.78 ± 09.85 years. The duration of haemodialysis ranged
from 1 to 12 years with mean of 7.84 ± 3.54 years. 46 (38.7%)
patients were diabetics and 77 (64.7%) patients were
hypertensive.
2.1. Vascular accesses
One hundred and seven patients were dialyzed through AVF,
ten patients were dialyzed through permanent tunneled cathe-
ters and two patients were dialyzed through AV graft. All
patients of the unit on HD were candidates for the study
except patients with obvious infection, malignancy, recently
created AVF and patients with temporary non-tunneled cathe-
ters were excluded from the study. All subjects of the study
were subjected to the following: thorough full history taking
and clinical examination, laboratory blood tests which
included: kidney function tests, Complete Blood Count
(CBC), single pool Kt/V, serum albumin by colorimetric
method, fasting blood sugar, swab culture and sensitivity from
the skin over the vascular access and blood culture and sensi-
tivity from both central and peripheral samples. Blood samples
for blood culture were taken before dialysis session. Under
complete aseptic condition, 10 mL of blood was taken through
the catheter and a peripheral vein puncture and injected into
two ‘‘blood bottles’’ with speciﬁc media for aerobic and anaer-
obic organisms and fungal infection. Also all patients under-
went radiological Doppler ultrasound examination to
evaluate the vascular access by high-resolution real-time B
mode ultrasonography with a 7.5-MHz linear transducer
(SSH 140A Toshiba, Japan). The examination involved 2D
and Doppler vascular access examination, with the former
allowing evaluation and detection of any abnormalities in
the vascular access such as stenosis, atheromatous plaque,
aneurysm, pattern of blood ﬂow and distal ischemia.
3. Statistical methods
Statistical analyses were performed with Statistical Package for
Social Sciences version 17.0 for Windows (SPSS Inc., Chicago,
IL). Continuous variables are presented as mean ± SD or
median and range. Chi-square test was used for qualitative
data (frequency and proportion), student t-test was used to
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more than 2 groups. Post Hoc test LSD (least signiﬁcance dif-
ference) was used for intra group differences. For non-
parametric data (median and range), Kruskal–Wallis test was
used to compare more than 2 groups and Mann–Whitney test
was used to compare between 2 groups. Risk factors for the
incident of infection were analyzed by logistic regression anal-
ysis. P is signiﬁcant if <0.05 at conﬁdence interval 95%.4. Results
Regarding the vascular complications in the studied subjects,
68 (57%) patients had stenosis of the access, 25 (21%) had
athermanous plaques and 44 (36.9%) patients had aneurysm.
There was signiﬁcant low Kt/V in patients with stenosis and
aneurysmal dilatation in comparison with patients without
theses complications (p< 0.001). On other hand , no signiﬁ-
cant differences were reported between patients with and those
without vascular complications (stenosis, aneurysmal dilata-
tion and atheromatous plaques) regarding age, duration of
HD session, random blood sugar, serum albumin level and
BMI Table 1.
Regarding prevalence of infection in the studied patients,
27 (22.7 %) had positive blood culture with 17 patients having
Staphylococcus aureus (S. aureus) infection, 6 patients having
pseudomonas infection and 4 patients having Klebsiella pneu-
moniae infection. There was no fungus infection Table 2.
Local Skin infection over the access, according to the swab
culture and sensitivity was reported for bacteria in 64 (53.7%)
patients with 57 (47.8%) having infection by S. aureus, 5
(4.2%) having infection with pseudomonas and 2 (1.6%)Table 1 Comparison between different vascular complications rega
Age (years)
Mean ± SD
Dialysis time (h)
Mean ± SD
Kt/V
Mean ±
Stenosis 46.30 ± 11.09 4.76 ± 3.12 1.52 ±
No stenosis 47.55 ± 9.16 5.14 ± 3.35 1.42±
P value 0.513 0.525 0.001
Aneurysm 47.59 ± 9.97 5.24 ± 3.46 1.51 ±
No aneurysm 46.0 ± 10.11 4.50 ± 2.81 1.411.5
P value 0.408 0.207 0.001
Atheromatous plaque 46.91 ± 9.5 5.0 ± 3.30 1.48 ±
No Atheromatous plaque 47.54 ± 12.2 4.85 ± 3.05 1.44 ±
P value 0.814 0.832 0.355
Table 2 Comparison between incidence of infection (local and syst
Age (years)
Mean ± SD
Dialysis time (h)
Mean ± SD
Kt/V
Mean ± SD
R
M
+ve blood culture 47.07 ± 13.3 4.53 ± 3.20 1.39 ± 0.18 1
ve blood culture 47.0 ± 9.10 5.09 ± 3.21 1.54±.41
P value 0.980 0.441 0.008 0
+ve swab culture 46.02 ± 9.88 4.02 ± 2.80 1.50 ± 0.15
ve swab culture 48.46 ± 9.36 3.26 ± 3.86 1.54 ± 0.54 1
P value 0.169 0.001 0.597 0patients with K. pneumoniae infection. Again no fungus infec-
tion was reported Table 3.
Signiﬁcant low Kt/V, low serum albumin level and low
BMI were observed in patients with systemic infection in com-
parison with patients without infection (p< 0.008, <0.008
and <0.001 respectively) Table 2.
For patients with local infection, there was signiﬁcant
increase in the duration of HD and random blood sugar, a
decrease in serum albumin level and in BMI in comparison
with patients without infection (p< 0.001, <0.036, <0.036
and <0.001 respectively) (Table 2).
When logistic regression analysis was done, we found sig-
niﬁcant increase in the risk of infection in male patients,
patients with low BMI, increased BUN and increased duration
of HD session (p< 046, <.008, <0.002 and <.009 respec-
tively) (Table 3).
In comparing diabetic and non-diabetic patients regarding
the incident of vascular abnormalities and incident of
infection, we found that the atheromatous plaques were signif-
icantly increased in diabetic patients in comparison with non-
diabetics (p< 0.008). The incident of local skin infection with
positive swab culture was statistically signiﬁcantly increased in
diabetic patients in comparison with non-diabetics (p< 0.001)
(Table 4).
The total incidents of vascular complication was
statistically higher in hypertensive group in comparison with
non-hypertensive group (p< 0.009) (Table 5).
Stenosis was the most common risk factor for vascular fail-
ure as it occurred in (29%) of our patients. DM was the second
common risk factor for vascular failure as it occurred in (17%)
of our patients. Hypertension (HTN) and Systemic infection
were the third common risk factor for vascular failure as theyrding different clinical and laboratory parameters.
SD
Random blood sugar
(mg/dl)
Mean ± SD
Serum albumin
(g/d)
Mean ± SD
BMI
Mean ± SD
0.14 108.8 ± 39.1 3.78 ± 0.43 22.42 ± 3.11
.16 120.1 ± 55.9 3.80 ± 0.49 23.41 ± 3.32
0.190 0.814 0.097
0.15 118.2 ± 54.7 3.76 ± 0.49 23.08 ± 3.41
1 ± 0.15 109 ± 35.2 3.85 ± 0.41 22.82 ± 3.01
0.600 0.286 0.665
0.15 114.5 ± 49.01 3.78 ± 0.46 23.14 ± 3.20
0.20 119.29 ± 52.09 3.85 ± 0.48 22.23 ± 3.52
0.685 0.521 0.245
emic) and different clinical and laboratory parameters.
andom blood sugar (mg/dl)
ean ± SD
Serum albumin (g/d)
Mean ± SD
BMI
Mean ± SD
11.50 ± 47.09 3.55 ± 0.51 20.93 ± 3.13
118.9 ± 51.67 3.86 ± 0.43 23.53 ± 3.13
.502 0.008 0.001
127.4 ± 57.9 3.90 ± 0.41 24.10 ± 3.09
08.07 ± 40.89 3.73 ± 0.46 22.0 ± 3.13
.036 0.036 0.001
Table 3 Comparison between incidence of infection and
different risk factors.
B S.E. Wald Sig.
BUN .038 .012 10.007 .002
Sex 1.122 .563 3.966 .046
BMI .238 .089 7.129 .008
Duration of dialysis (h) .234 .090 6.755 .009
Table 4 Vascular complications in diabetic and non-diabetic
patients.
Non diabetic
patients (n= 73)
Diabetic patients
(n= (46)
v2 P
No % No %
Atheromatous plaque
Present 10 11.6 15 31.8 7.009 0.008
Absent 63 88.4 31 68.2
Culture swab of the vascular access
Positive 29 39.4 33 72.7 12.065 0.001
Negative 44 60.6 13 27.3
Table 5 Vascular complications in hypertensive and non-
hypertensive patients.
HTN (n= 77) No HTN (n= 42) v2 P
No % No %
Present 38 49.4 9 21.4 6.750 0.009
Absent 39 50.6 33 78.6
70 T.A. Ghonemy et al.occurred in (14%) of our patients. The lowest complications
were aneurysmal dilation in 13.6% of the patients, atheroma-
tous plaques in 8% of the patients and local exit site infection
in 3% of the patients.
5. Discussion
Long-term patency of vascular access has prolonged survival
of thousands of patients with ESRD on maintenance HD.7
AVF is the preferred access for patients who require regular
HD and the preferred site is the wrist, preferably in the non-
dependent arm.2
Complications of AVF include thrombosis, infection,
bleeding, increased venous pressure, arterial insufﬁciency,
aneurysm, carpal tunnel syndrome, distal ischemia and even
heart failure.6 In the current study, stenosis of the vascular
access was the most common complication as it occurred in
about 53% of the patients. Infection of the vascular access
was the second common complication as it occurred in more
than 50% of the patients. The incidence of Systemic infection
occurred in 22% of the patients. Stenosis may have occurred
partly due to excessive in-growth of ﬁbrous tissue through
multiple puncture holes, and partly due to repeated attacks
of hypotension during and after the hemodialysis. The result
of our study does not go in harmony with the study done byDerakhshanfar and his colleagues,8 who reported that the
most frequently encountered complication in the vascular
access was aneurysm (51%), followed by venous hypertension
(16.7%), infection (4.4%), thrombosis (3.3%), and arterial
steal syndrome (1.1%).
In the current study, Staphylococcus infection was the most
common type of infections, this goes in agreement with
Ratnaja and Susan 9 who reported that the prevalence of S.
aureus in patients on hemodialysis is 35–62%. In the study
of Astor and his coworkers 5, the prevalence of
Staphylococcus aureus (S. aureus) nasal carriage in patients
on hemodialysis is 35–62%, a factor that might predispose
these patients to S. aureus. Jean et al. 10 found that central
venous catheter-related bloodstream infection (CRBSI) with
S. aureus occurred most often in patients who had nasal colo-
nization; in more than 50% of the infected patients, the same
strain of S. aureus was detected in nose (or skin) and catheter.
Kt/V decreased signiﬁcantly in our patients with stenosis of
the vascular access; this was in harmony with the study of
Campos et al. 11 who reported that stenosis is considered the
major cause of dysfunction of arteriovenous ﬁstula that leads
to decreasing Kt/V and decreasing the efﬁcacy of hemodialysis.
Kt/V decreased signiﬁcantly in patients with stenosis of the
vascular access which may be due to the decrease in the blood
ﬂow rate in AVF and recirculation of blood. Recirculation
occurs when dialyzed blood returning through the venous nee-
dle re-enters the extracorporeal circuit through the arterial nee-
dle, rather than returning to the systemic circulation that leads
to decrease in urea removal and decrease Kt/V.15
Kt/V decreased signiﬁcantly in patients with aneurysm of
the vascular access; which may also be due to recirculation
of the blood at the AVF. It is not going with the results of
Yu et al. 12 who reported that there are no signiﬁcant differ-
ences in Kt/V between the patients with aneurysm of the vas-
cular access and the patients without aneurysm.
The incidence of atheromatous plaque of the vascular
access was high in our patients with DM, this was in agreement
with Danese et al. 13 who reported that there is a signiﬁcant
relationship between diabetes and the presence of non-
ulcerative plaques.
A signiﬁcant relationship between Diabetes Mellitus (DM)
and positive culture swap of the vascular access was reported
in our patients. Infection of the vascular access is increased
in patients with DM which goes hand in hand with the study
of Ratnaja and Susan 9 who reported that DM is an important
risk factor for the incidence of infection. He reported also
many risk factors for CRBSI such as older age, higher total
intravenous iron dose, increased recombinant human erythro-
poietin dose, lower hemoglobin level, lower serum albumin
level, diabetes mellitus, peripheral atherosclerosis, and recent
hospitalization or surgery.
Stenosis was the most common risk factor for vascular fail-
ure, as it occurred in (29%) of our patients with stenosis. DM
was the second common risk factor as vascular failure
occurred in (17%) of the patients with DM. Hypertension
and Systemic infection were the third common risk factor as
they occurred in (14%) of patients with HTN. This was in
agreement to Mauricio et al. 14 who reported the stenosis to
be the most common risk factor for vascular failure (51% of
patients with stenosis) followed by diabetes mellitus as the sec-
ond common risk factor for vascular failure (occurred in
(14%) of their diabetic patients. Hypertension was the third
Vascular access complications in hemodialysis patients 71common risk factor for vascular failure (13%) of their patients
with HTN.
6. Conclusion
Stenosis and infection are the most common complications of
the vascular access. Staphylococcus infection is the commonest
type of infection. Risk factors for dialysis CRBSI include
Diabetes, older age, low serum albumin, high BUN and
decreasing the duration of dialysis session.
Limitations
It is a cross sectional study on a small numbers of patients and
in a single center and of course, it will be of better value if it
was done in a multicenter design on a larger number of
patients.
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